| Literature DB >> 27096079 |
Lisa R Goshe1, Melissa L Snover2, Aleta A Hohn1, George H Balazs2.
Abstract
Somatic growth rate data for wild sea turtles can provide insight into life-stage durations, time to maturation, and total lifespan. When appropriately validated, the technique of skeletochronology allows prior growth rates of sea turtles to be calculated with considerably less time and labor than required by mark--recapture studies. We applied skeletochronology to 10 dead, stranded green turtles Chelonia mydas that had previously been measured, tagged, and injected with OTC (oxytetracycline) during mark-recapture studies in Hawaii for validating skeletochronological analysis. We tested the validity of back-calculating carapace lengths (CLs) from diameters of LAGs (lines of arrested growth), which mark the outer boundaries of individual skeletal growth increments. This validation was achieved by comparing CLs estimated from measurements of the LAG proposed to have been deposited closest to the time of tagging to actual CLs measured at the time of tagging. Measureable OTC-mark diameters in five turtles also allowed us to investigate the time of year when LAGs are deposited. We found no significant difference between CLs measured at tagging and those estimated through skeletochronology, which supports calculation of somatic growth rates by taking the difference between CLs estimated from successive LAG diameters in humerus bones for this species. Back-calculated CLs associated with the OTC mark and growth mark deposited closest to tagging indicated that annual LAGs are deposited in the spring. The results of this validation study increase confidence in utilization of skeletochronology to rapidly obtain accurate age and growth data for green turtles.Entities:
Keywords: Chelonia mydas; growth rate; line of arrested growth; mark–recapture; oxytetracycline; skeletochronology
Year: 2016 PMID: 27096079 PMCID: PMC4829045 DOI: 10.1002/ece3.2108
Source DB: PubMed Journal: Ecol Evol ISSN: 2045-7758 Impact factor: 2.912
Comparison of carapace lengths measured at tagging with those back‐calculated from growth mark diameters within stained humerus cross‐sections from Hawaiian green turtles Chelonia mydas. Date is day‐month‐year. SCL = straightline carapace length (cm). LAG = line of arrested growth.
| ID | Date stranded | SCL at stranding | Date tagged | SCL at tagging | Estimated SCL at tagging | Year LAG deposited | Difference in SCL |
|---|---|---|---|---|---|---|---|
| CM‐1 | 8‐2‐99 | 58.5 | 23‐4‐97 | 55.1 | 55.1 | 1997 | 0.0 |
| CM‐4 | 10‐12‐99 | 69.6 | 21‐12‐98 | 69.4 | 69.6 | 1999 | −0.2 |
| CM‐6 | 9‐5‐00 | 56.3 | 5‐10‐99 | 55.9 | 56.3 | 2000 | −0.4 |
| CM‐8 | 20‐2‐01 | 70 | 24‐4‐00 | 70.6 | 70.0 | 2000 | 0.6 |
| CM‐9 | 23‐4‐01 | 44.5 | 14‐4‐00 | 44.7 | 44.3 | 2000 | 0.4 |
| CM‐10 | 11‐12‐01 | 85.5 | 25‐4‐00 | 83.8 | 84.6 | 2000 | −0.8 |
| CM‐11 | 28‐3‐02 | 57.2 | 8‐7‐97 | 54.8 | 54.8 | 1997 | 0.0 |
| CM‐12 | 17‐10‐02 | 60.2 | 12‐5‐98 | 57.4 | 57.7 | 1998 | −0.3 |
| CM‐13 | 19‐10‐03 | 69.5 | 17‐6‐94 | 45.5 | 47.0 | 1994 | −1.5 |
| CM‐14 | 14‐7‐04 | 53.7 | 16‐5‐00 | 51 | 51.0 | 2000 | 0.0 |
| Mean absolute difference: | 0.4 (0.3) | ||||||
SCL at stranding was not measured. SCL is that measured when turtle was captured 3 months before death.
Possible observer measurement error (SCL) or shrinking turtle; SCL measured at stranding was less than that measured at tagging.
SCL back‐calculated using the oxytetracycline mark diameter; 1994 LAG within resorption core and not measurable in stained cross‐section.
Mean absolute difference calculated without CM‐13.
Fibropapilloma tumors were present.
Comparison of back‐calculated straightline carapace lengths (SCLs) of OTC (oxytetracycline) marks and corresponding LAG (line of arrested growth) diameters representing the years closest to OTC injection dates to assess the timing of LAG deposition in Hawaiian green sea turtle Chelonia mydas humeri. Date is day‐month‐year. Parentheses indicate the difference and direction of error between SCLs measured at OTC injection and back‐calculated from the diameter of the OTC mark with the mean absolute difference and SE (standard error)
| ID | OTC date | OTC section back‐calculated SCL | Stained section back‐calculated SCL | LAG year |
|---|---|---|---|---|
| CM‐1 | 23‐4‐97 | 55.9 (−0.8) | 55.1 | 1997 |
| CM‐4 | 21‐12‐98 | 69.4 (0.0) | 69.6 | 1999 |
| CM‐11 | 8‐7‐97 | 55.0 (−0.2) | 54.8 | 1997 |
| CM‐12 | 12‐5‐98 | 57.7 (−0.3) | 57.7 | 1998 |
| CM‐14 | 16‐5‐00 | 51.0 (0.0) | 51.0 | 2000 |
| Mean difference ± SE | 0.3 ± 0.1 | |||
Figure 1Green turtle humerus cross‐section for CM‐12 viewed under ultraviolet light with fluorescent OTC (oxytetracycline) mark visible (indicated by black dotted line) next to stained cross‐section with years assigned to growth marks. Turtle was OTC injected on 12 May 1998 and measured 57.4 cm SCL (straightline carapace length). 1998 LAG (line of arrested growth) was a closely spaced double interpreted as 1 annual LAG according to Goshe et al. (2010) and Snover et al. (2011). Both the diameter of the OTC mark and 1998 LAG yielded a back‐calculated SCL of 57.7 cm, indicating that the timing of deposition for each was similar. White bar indicates 1 mm.